Inspection Record

HK Kolmar Canada, Inc. — Health Canada Inspection Findings

Health CanadaInspected 2021-03-29 22 findingsComplaint and recall handlingQuality unit oversightOther quality systemEquipment and facilityLaboratory and QC controlsTraining and personnelStability and storageDeviation, CAPA, and investigationCleaning validationComputer system validationRegulatory reporting and change control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

2Quality unit oversight

The annual product quality review procedure was inadequate.

3Other quality system

The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

4Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

5Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

6Other quality system

The company's monitoring of water testing was inadequate.

7Laboratory and QC controls

The quality control department did not appropriately approve, assess, and/or document the reprocessing and/or reworking of a lot and/or batch. The reworked lot was not included in the ongoing stability program (the testing of drug samples over time).

8Other quality system

Lots or batches of finished product did not comply with the specifications and were made available for further fabrication or sale.

9Other quality system

The monitoring procedures for microbial and/or environmental conditions were inadequate.

10Training and personnel

The ongoing training of personnel was inadequate.

11Stability and storage

The evidence used to demonstrate the transportation and/or storage conditions of each lot or batch of the drug was inadequate.

12Equipment and facility

The equipment was not set-up, designed, operated, stored, and/or maintained to prevent potential contamination of drugs by other drugs and/or by foreign material.

13Equipment and facility

The establishment and/or the maintenance of a data governance plan was inadequate.

14Complaint and recall handling

The written procedures for recalls were inadequate.

15Stability and storage

The procedures in place were inadequate for the storage, transportation, records, and/or testing of purchased media.

16Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

17Cleaning validation

The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

18Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

19Other quality system

The implementation of a self-inspection program was inadequate.

20Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

21Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

22Other quality system

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2021-03-29. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

HK Kolmar Canada, Inc. company profile — full history Health Canada documents, 2021 Go to Findings search